89 related articles for article (PubMed ID: 23404739)
1. Optimization of marine triterpene sipholenols as inhibitors of breast cancer migration and invasion.
Foudah AI; Jain S; Busnena BA; El Sayed KA
ChemMedChem; 2013 Mar; 8(3):497-510. PubMed ID: 23404739
[TBL] [Abstract][Full Text] [Related]
2. Optimization, pharmacophore modeling and 3D-QSAR studies of sipholanes as breast cancer migration and proliferation inhibitors.
Foudah AI; Sallam AA; Akl MR; El Sayed KA
Eur J Med Chem; 2014 Feb; 73():310-24. PubMed ID: 24487236
[TBL] [Abstract][Full Text] [Related]
3. The marine-derived sipholenol A-4-O-3',4'-dichlorobenzoate inhibits breast cancer growth and motility in vitro and in vivo through the suppression of Brk and FAK signaling.
Akl MR; Foudah AI; Ebrahim HY; Meyer SA; El Sayed KA
Mar Drugs; 2014 Apr; 12(4):2282-304. PubMed ID: 24736807
[TBL] [Abstract][Full Text] [Related]
4. Sipholane triterpenoids: chemistry, reversal of ABCB1/P-glycoprotein-mediated multidrug resistance, and pharmacophore modeling.
Jain S; Abraham I; Carvalho P; Kuang YH; Shaala LA; Youssef DT; Avery MA; Chen ZS; El Sayed KA
J Nat Prod; 2009 Jul; 72(7):1291-8. PubMed ID: 19534474
[TBL] [Abstract][Full Text] [Related]
5. Sipholenol A, a marine-derived sipholane triterpene, potently reverses P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells.
Shi Z; Jain S; Kim IW; Peng XX; Abraham I; Youssef DT; Fu LW; El Sayed K; Ambudkar SV; Chen ZS
Cancer Sci; 2007 Sep; 98(9):1373-80. PubMed ID: 17640301
[TBL] [Abstract][Full Text] [Related]
6. Reversal of P-glycoprotein-mediated multidrug resistance by sipholane triterpenoids.
Jain S; Laphookhieo S; Shi Z; Fu LW; Akiyama S; Chen ZS; Youssef DT; van Soest RW; El Sayed KA
J Nat Prod; 2007 Jun; 70(6):928-31. PubMed ID: 17488128
[TBL] [Abstract][Full Text] [Related]
7. Esters of the marine-derived triterpene sipholenol A reverse P-GP-mediated drug resistance.
Zhang Y; Zhang YK; Wang YJ; Vispute SG; Jain S; Chen Y; Li J; Youssef DT; El Sayed KA; Chen ZS
Mar Drugs; 2015 Apr; 13(4):2267-86. PubMed ID: 25874923
[TBL] [Abstract][Full Text] [Related]
8. Marine sponge-derived sipholane triterpenoids reverse P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells.
Abraham I; Jain S; Wu CP; Khanfar MA; Kuang Y; Dai CL; Shi Z; Chen X; Fu L; Ambudkar SV; El Sayed K; Chen ZS
Biochem Pharmacol; 2010 Nov; 80(10):1497-506. PubMed ID: 20696137
[TBL] [Abstract][Full Text] [Related]
9. Biocatalysis of the anticancer sipholane triterpenoids.
Jain S; Shirode A; Yacoub S; Barbo A; Sylvester PW; Huntimer E; Halaweish F; El Sayed KA
Planta Med; 2007 Jun; 73(6):591-6. PubMed ID: 17486535
[TBL] [Abstract][Full Text] [Related]
10. New inhibitors of RANKL-induced Osteoclastogenesis from the marine sponge Siphonochalina siphonella.
El-Beih AA; El-Desoky AH; Al-Hammady MA; Elshamy AI; Hegazy MF; Kato H; Tsukamoto S
Fitoterapia; 2018 Jul; 128():43-49. PubMed ID: 29729401
[TBL] [Abstract][Full Text] [Related]
11. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.
Ma JG; Huang H; Chen SM; Chen Y; Xin XL; Lin LP; Ding J; Liu H; Meng LH
Breast Cancer Res Treat; 2011 Nov; 130(1):85-96. PubMed ID: 21181437
[TBL] [Abstract][Full Text] [Related]
12. Olive secoiridoids and semisynthetic bioisostere analogues for the control of metastatic breast cancer.
Busnena BA; Foudah AI; Melancon T; El Sayed KA
Bioorg Med Chem; 2013 Apr; 21(7):2117-27. PubMed ID: 23403296
[TBL] [Abstract][Full Text] [Related]
13. Discovery, optimization, and pharmacophore modeling of oleanolic acid and analogues as breast cancer cell migration and invasion inhibitors through targeting Brk/Paxillin/Rac1 axis.
Elsayed HE; Akl MR; Ebrahim HY; Sallam AA; Haggag EG; Kamal AM; El Sayed KA
Chem Biol Drug Des; 2015 Feb; 85(2):231-43. PubMed ID: 24954090
[TBL] [Abstract][Full Text] [Related]
14. Redox-silent tocotrienol esters as breast cancer proliferation and migration inhibitors.
Behery FA; Elnagar AY; Akl MR; Wali VB; Abuasal B; Kaddoumi A; Sylvester PW; El Sayed KA
Bioorg Med Chem; 2010 Nov; 18(22):8066-75. PubMed ID: 20943398
[TBL] [Abstract][Full Text] [Related]
15. Marine natural products-inspired phenylmethylene hydantoins with potent in vitro and in vivo antitumor activities via suppression of Brk and FAK signaling.
Sallam AA; Mohyeldin MM; Foudah AI; Akl MR; Nazzal S; Meyer SA; Liu YY; El Sayed KA
Org Biomol Chem; 2014 Jul; 12(28):5295-303. PubMed ID: 24927150
[TBL] [Abstract][Full Text] [Related]
16. Semisynthetic analogues of the marine cembranoid sarcophine as prostate and breast cancer migration inhibitors.
Hassan HM; Sallam AA; Mohammed R; Hifnawy MS; Youssef DT; El Sayed KA
Bioorg Med Chem; 2011 Aug; 19(16):4928-34. PubMed ID: 21775154
[TBL] [Abstract][Full Text] [Related]
17. Impact of protein tyrosine kinase 6 (PTK6) on human epidermal growth factor receptor (HER) signalling in breast cancer.
Ludyga N; Anastasov N; Gonzalez-Vasconcellos I; Ram M; Höfler H; Aubele M
Mol Biosyst; 2011 May; 7(5):1603-12. PubMed ID: 21380407
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of isoliquiritigenin on the migration and invasion of human breast cancer cells.
Wang KL; Hsia SM; Chan CJ; Chang FY; Huang CY; Bau DT; Wang PS
Expert Opin Ther Targets; 2013 Apr; 17(4):337-49. PubMed ID: 23327692
[TBL] [Abstract][Full Text] [Related]
19. Cdc42 negatively regulates intrinsic migration of highly aggressive breast cancer cells.
Zuo Y; Wu Y; Chakraborty C
J Cell Physiol; 2012 Apr; 227(4):1399-407. PubMed ID: 21618528
[TBL] [Abstract][Full Text] [Related]
20. Frondoside A inhibits human breast cancer cell survival, migration, invasion and the growth of breast tumor xenografts.
Al Marzouqi N; Iratni R; Nemmar A; Arafat K; Ahmed Al Sultan M; Yasin J; Collin P; Mester J; Adrian TE; Attoub S
Eur J Pharmacol; 2011 Oct; 668(1-2):25-34. PubMed ID: 21741966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
